MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

09 Feb 2022 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release on February 09,2021 titled ‘Glenmark launches Nitric Oxide Nasal Spray (FabiSpray®) in India for the Treatment of Adult Patients with COVID-19 in partnership with SaNOtiz’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..